Press Release
Article Category

Amyotrophic lateral sclerosis (ALS)
Review over Amyotrophic Lateral Sclerosis (ALS) and the First FDA-Approved Drug for Treatment of

Molnupiravir
Molnupiravir may be effective against the omicron sub-variant BA.5 According to a study

Monkeypox
The current monkeypox situation is consistently evolving and subject to change. The aim of

Arthritis
World AUTO immune & AUTO inflammatory Arthritis Day This event historically unites thousands

WHO Backs Molnupiravir for High-Risk Covid-19 Patients
The ninth update of WHO’s guideline on COVID-19 therapeutics includes a conditional recommendation

Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS) Global Day Annually the International ALS/MND Associations celebrates 21 June

Breaking news; U.S FDA advisory panel narrowly endorses Molnupiravir
Breaking news; U.S FDA advisory panel narrowly endorses Molnupiravir U.S FDA advisory panel